• 1
    Gabbe SJ. Obstetrics: normal and problems in pregnancy. In: SameulP, ColomboDF, eds. Chronic Renal Disease in Pregnancy. Orlando: Churchill Livingstone, 2000: 10721076.
  • 2
    McGovern MM, Desnick RJ. Lysosomal storage diseases. In: GoldmanL, ed. Cecil Textbook of Medicine. St Louis: W.B. Saunders Company, 2000: 11041107.
  • 3
    Desnick R. Alpha galactosidase A deficiency: Fabry disease. In: ScriverCR, SlyWS, eds. Scriver's: The Metabolic Bases of Inherited Diseases 8th edn. Columbus: McGraw-Hill Professional, 2000; 3: 37333774.
  • 4
    Cohen A, Nast C. Renal pathology. In: AndersonWAD, eds. Anderson's Pathology, 10th edn. St Louis: Mosby-Year Book, 1996: 2085.
  • 5
    Gubler MC, Lenoir G, Grunfeld JP, Ulmann A, Droz D, Habib R. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 1978; 13: 223235.
  • 6
    Grunfeld JP, Lidove O, Barbey F. Heterozygotes with Fabry's disease. Contrib Nephrol 2001; 136: 208210.
  • 7
    Schiffmann R, Kopp JB, Austin HA 3rd et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 27432749.
  • 8
    Eng CM, Guffon N, Wilcox WR et al. Safety and efficacy of recombinant human alpha-galactosidase A – replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 916.
  • 9
    Ojo A, Meier-Kriesche HU, Friedman G et al. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 2000; 69: 23372339.
  • 10
    Grunfeld JP, Le Porrier M, Droz D, Bensaude I, Hinglais N, Crosnier J. La transplantation renale chez les sujets atteints de maladie de Fabry Transplantation du rein d'un sujet heterozygote a un sujet sain. Nouv Presse Med 1975; 4: 20812085.